To understand why drug prices are rising rapidly while drug innovation lags, it’s helpful to look at how biopharmaceutical research and development (R&D) has changed. This evolution has led to a conglomerate of monopolies.
A recent JAMA article proposing a different way of measuring hospitals’ sepsis care contained for me a powerful “between the lines” message. “Could this have saved Brad from having parts of both arms and legs amputated?”
The general population of men who had taken ED drugs had a 13% lower rate of MACE, 25% lower rate of mortality and 39% lower rate of CV mortality when compared to men who had not been exposed to ED drugs.
A Project Veritas video claimed that it featured someone named “Jordon Trishton Walker, Pfizer Director of Research and Development – Strategic Operations and mRNA Scientific Planning.”